Gracellbio
3 known investors
Gracell develops CAR-T cell therapies aimed at delivering fast, deep, and durable responses for patients with cancer and autoimmune disease. It is a biotechnology company and a member of the AstraZeneca group.
BiotechHealthtech
Investors · 3
Frequently asked questions
- What does Gracellbio do?
- Gracell develops CAR-T cell therapies aimed at delivering fast, deep, and durable responses for patients with cancer and autoimmune disease. It is a biotechnology company and a member of the AstraZeneca group.
- Who are Gracellbio's investors?
- Gracellbio's investors include LAV, Lilly Asia Ventures, OrbiMed.